BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 28560780)

  • 1. Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer.
    Marucci L; Farneti A; Di Ridolfi P; Pinnaro P; Pellini R; Giannarelli D; Vici P; Conte M; Landoni V; Sanguineti G
    Head Neck; 2017 Sep; 39(9):1761-1769. PubMed ID: 28560780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
    Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebamipide gargle in preventive management of chemo-radiotherapy induced oral mucositis.
    Chaitanya B; Pai KM; Yathiraj PH; Fernandes D; Chhaparwal Y
    Oral Oncol; 2017 Sep; 72():179-182. PubMed ID: 28797456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms.
    Su CK; Mehta V; Ravikumar L; Shah R; Pinto H; Halpern J; Koong A; Goffinet D; Le QT
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):171-7. PubMed ID: 15337553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study.
    Sharma A; Rath GK; Chaudhary SP; Thakar A; Mohanti BK; Bahadur S
    Eur J Cancer; 2012 Apr; 48(6):875-81. PubMed ID: 21741230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.
    Yokota T; Ogawa T; Takahashi S; Okami K; Fujii T; Tanaka K; Iwae S; Ota I; Ueda T; Monden N; Matsuura K; Kojima H; Ueda S; Sasaki K; Fujimoto Y; Hasegawa Y; Beppu T; Nishimori H; Hirano S; Naka Y; Matsushima Y; Fujii M; Tahara M
    BMC Cancer; 2017 May; 17(1):314. PubMed ID: 28476132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial.
    Tsujimoto T; Yamamoto Y; Wasa M; Takenaka Y; Nakahara S; Takagi T; Tsugane M; Hayashi N; Maeda K; Inohara H; Uejima E; Ito T
    Oncol Rep; 2015 Jan; 33(1):33-9. PubMed ID: 25351453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, randomized pilot study of bioadhesive chlorhexidine gel in the prevention and treatment of mucositis induced by chemoradiotherapy of head and neck cancer.
    Diaz-Sanchez RM; Pachón-Ibáñez J; Marín-Conde F; Rodríguez-Caballero Á; Gutierrez-Perez JL; Torres-Lagares D
    Med Oral Patol Oral Cir Bucal; 2015 May; 20(3):e378-85. PubMed ID: 25662553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for Head and Neck Cancer.
    Giralt J; Tao Y; Kortmann RD; Zasadny X; Contreras-Martinez J; Ceruse P; Arias de la Vega F; Lalla RV; Ozsahin EM; Pajkos G; Mazar A; Attali P; Bossi P; Vasseur B; Sonis S; Henke M; Bensadoun RJ
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):320-328. PubMed ID: 31669562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation.
    Antunes HS; Herchenhorn D; Small IA; Araújo CM; Viégas CM; Cabral E; Rampini MP; Rodrigues PC; Silva TG; Ferreira EM; Dias FL; Ferreira CG
    Radiother Oncol; 2013 Nov; 109(2):297-302. PubMed ID: 24044799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of Zataria extract mouthwash for the management of radiation-induced oral mucositis in patients: a randomized placebo-controlled double-blind study.
    Aghamohammadi A; Moslemi D; Akbari J; Ghasemi A; Azadbakht M; Asgharpour A; Hosseinimehr SJ
    Clin Oral Investig; 2018 Jul; 22(6):2263-2272. PubMed ID: 29313134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer.
    Anderson CM; Lee CM; Saunders DP; Curtis A; Dunlap N; Nangia C; Lee AS; Gordon SM; Kovoor P; Arevalo-Araujo R; Bar-Ad V; Peddada A; Colvett K; Miller D; Jain AK; Wheeler J; Blakaj D; Bonomi M; Agarwala SS; Garg M; Worden F; Holmlund J; Brill JM; Downs M; Sonis ST; Katz S; Buatti JM
    J Clin Oncol; 2019 Dec; 37(34):3256-3265. PubMed ID: 31618127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.
    Legouté F; Bensadoun RJ; Seegers V; Pointreau Y; Caron D; Lang P; Prévost A; Martin L; Schick U; Morvant B; Capitain O; Calais G; Jadaud E
    Radiat Oncol; 2019 May; 14(1):83. PubMed ID: 31118057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment.
    Lozano A; Marruecos J; Rubió J; Farré N; Gómez-Millán J; Morera R; Planas I; Lanzuela M; Vázquez-Masedo MG; Cascallar L; Giralt J; Escames G; Valentí V; Grima P; Bosser R; Tarragó C; Mesía R
    Clin Transl Oncol; 2021 Sep; 23(9):1801-1810. PubMed ID: 33738704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (>50 Gy) with or without chemotherapy.
    Rastogi M; Khurana R; Revannasiddaiah S; Jaiswal I; Nanda SS; Gupta P; Chufal KS; Bhatt ML
    Support Care Cancer; 2017 May; 25(5):1439-1443. PubMed ID: 27987094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The post hoc analysis comparing the severity grades of chemoradiotherapy-induced oral mucositis scored between the central and local assessors in a multicenter, randomized controlled trial of rebamipide for head and neck cancer.
    Ueno T; Zenda S; Konishi T; Yurikusa T; Shibasaki Y; Nagamoto H; Fujii M
    Int J Clin Oncol; 2019 Mar; 24(3):241-247. PubMed ID: 30426268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease.
    Harrington K; Berrier A; Robinson M; Remenar E; Housset M; de Mendoza FH; Fayette J; Mehanna H; El-Hariry I; Compton N; Franklin N; Biswas-Baldwin N; Lau M; Legenne P; Kumar R
    Eur J Cancer; 2013 May; 49(7):1609-18. PubMed ID: 23265705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study.
    Rao S; Dinkar C; Vaishnav LK; Rao P; Rai MP; Fayad R; Baliga MS
    Integr Cancer Ther; 2014 May; 13(3):201-10. PubMed ID: 24165896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of immunonutrition in patients with head and neck cancer receiving chemoradiation: A phase II randomized, double-blind study.
    Dechaphunkul T; Arundon T; Raungkhajon P; Jiratrachu R; Geater SL; Dechaphunkul A
    Clin Nutr; 2022 Feb; 41(2):433-440. PubMed ID: 35007812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer.
    Cerchietti LC; Navigante AH; Lutteral MA; Castro MA; Kirchuk R; Bonomi M; Cabalar ME; Roth B; Negretti G; Sheinker B; Uchima P
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1330-7. PubMed ID: 16765532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.